Literature DB >> 20924136

Comparative analysis of adherence, viability, proliferation and morphology of umbilical cord tissue-derived mesenchymal stem cells seeded on different titanium-coated expanded polytetrafluoroethylene scaffolds.

Trixi Hollweck1, Michaela Marschmann, Isabel Hartmann, Bassil Akra, Bruno Meiser, Bruno Reichart, Markus Eblenkamp, Erich Wintermantel, Günther Eissner.   

Abstract

Umbilical cord tissue comprises an attractive new source for mesenchymal stem cells. Umbilical cord tissue-derived mesenchymal stem cells (UCMSC) exhibit self-renewal, multipotency and immunological naivity, and they can be obtained without medical intervention. The transfer of UCMSC to the ischemic region of the heart may have a favorable impact on tissue regeneration. Benefit from typical cell delivery by injection to the infarcted area is often limited due to poor cell retention and survival. Another route of administration is to use populated scaffolds implanted into the infarcted zone. In this paper, the seeding efficiency of UCMSC on uncoated and titanium-coated expanded polytetrafluoroethylene (ePTFE) scaffolds with different surface structures was determined. Dualmesh (DM) offers a corduroy-like surface in contrast to the comparatively planar surface of cardiovascular patch (CVP). The investigation of adherence, viability and proliferation of UCMSC demonstrates that titanium-coated scaffolds are superior to uncoated scaffolds, independent of the surface structure. Microscopic images reveal spherical UCMSC seeded on uncoated scaffolds. In contrast, UCMSC on titanium-coated scaffolds display their characteristic spindle-shaped morphology and a homogeneous coverage of CVP. In summary, titanium coating of clinically approved CVP enhances the retention of UCMSC and thus offers a potential cell delivery system for the repair of the damaged myocardium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20924136     DOI: 10.1088/1748-6041/5/6/065004

Source DB:  PubMed          Journal:  Biomed Mater        ISSN: 1748-6041            Impact factor:   3.715


  4 in total

1.  A novel pulsatile bioreactor for mechanical stimulation of tissue engineered cardiac constructs.

Authors:  Trixi Hollweck; Bassil Akra; Simon Häussler; Peter Uberfuhr; Christoph Schmitz; Stefan Pfeifer; Markus Eblenkamp; Erich Wintermantel; Günther Eissner
Journal:  J Funct Biomater       Date:  2011-07-20

Review 2.  Prospects for the therapeutic development of umbilical cord blood-derived mesenchymal stem cells.

Authors:  Soyoun Um; Jueun Ha; Soo Jin Choi; Wonil Oh; Hye Jin Jin
Journal:  World J Stem Cells       Date:  2020-12-26       Impact factor: 5.326

Review 3.  Mesenchymal stem cells from umbilical cord tissue as potential therapeutics for cardiomyodegenerative diseases - a review.

Authors:  Trixi Hollweck; Christian Hagl; Günther Eissner
Journal:  Int J Mol Cell Med       Date:  2012

4.  Umbilical cord tissue-derived mesenchymal stem cells induce apoptosis in PC-3 prostate cancer cells through activation of JNK and downregulation of PI3K/AKT signaling.

Authors:  Ihn Han; Miyong Yun; Eun-Ok Kim; Bonglee Kim; Min-Hyung Jung; Sung-Hoon Kim
Journal:  Stem Cell Res Ther       Date:  2014-04-16       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.